Showing results (1731-1740 of 2,025) with videos related to
Sort By:
Pageof 203
Annals of Hepatology|September 21, 2019
Direct antiviral therapy for treatment of hepatitis C: A real-world study from BrazilCirley Maria de Oliveira Lobato, Liana Codes, Giovanni Faria Silva, et al.Annals of Hepatology|February 1, 2021
Roles of diencephalon/mesencephalon homeobox 1 in the development and prognosis of hepatocellular carcinomaXiaoting Huang, Leyang Xiang, Wei Liu, et al.Annals of Hepatology|September 28, 2019
Characteristics of intestinal bacteria with fatty liver diseases and cirrhosisGuohong-Liu, Qingxi-Zhao, Hongyun-WeiAnnals of Hepatology|September 28, 2019
Can Prohibitin 1 be a Safeguard against liver disease?Lei Xia, Yuling Liu, Sujun Zhang, et al.Annals of Hepatology|April 20, 2011
Lipid-bound sialic acid (LSA) in liver diseases of different etiologiesLech Chrostek, Bogdan Cylwik, Anatol Panasiuk, et al.Annals of Hepatology|April 20, 2011
The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: A systematic review and meta-analysisZhou Yi, Yuan Wei Jie, Zhu NanAnnals of Hepatology|April 20, 2011
Aminoguanidine potentiates the hepatoprotective effect of silymarin in CCL4 treated ratsAhmed Fahmy Ahmed, Mona Fouad Mahmoud, Marwa Arafat Ouf, et al.Annals of Hepatology|June 17, 2011
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trialLisa B Van Wagner, Sean W P Koppe, Elizabeth M Brunt, et al.Annals of Hepatology|June 17, 2011
Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of in-hospital mortality. A prospective studyJosé Alberto González-González, Diego García-Compean, Genaro Vázquez-Elizondo, et al.Annals of Hepatology|February 9, 2011
Prevalence and risk factors for bacterial skin infection and mortality in cirrhosisPazhanivel Mohan, Bhavadharani Ramu, Emmanuel Bhaskar, et al.Pageof 203